Tandem Diabetes Care (TNDM) Restructuring Costs (2025)
Tandem Diabetes Care's (TNDM) quarterly Restructuring Costs came in at $20.0 million in Q2 2025.
Powered by 
Analysis
Tandem Diabetes Care (TNDM) Restructuring Costs (2025) Analysis & Trends
Tandem Diabetes Care (TNDM) has reported Restructuring Costs for 1 consecutive years, with $20.0 million the latest figure, recorded in Q2 2025.
- For the quarter ending Q2 2025, Restructuring Costs changed N/A year-over-year to $20.0 million; the trailing twelve-month figure through Jun 2026 stood at $20.0 million (changed 0.0% YoY), and the FY2025 full-year result was $20.0 million, changed N/A from the prior year.
- Restructuring Costs steadied at $20.0 million in Q2 2025 per TNDM's latest filing.
- Across five years, Restructuring Costs topped out at $20.0 million in Q2 2025 and bottomed at $20.0 million in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.94 Bn | 175.34 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.83 Bn | 122.62 Bn | 1.96 Bn |
| 3 | Medtronic | 116.96 Bn | 108.14 Bn | 6.34 Bn |
| 4 | Stryker | 104.44 Bn | 100.97 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.87 Bn | 63.33 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.91 Bn | 45.65 Bn | 1.35 Bn |
| 7 | Alcon | 33.06 Bn | 31.60 Bn | 1.68 Bn |
| 8 | Dexcom | 32.22 Bn | 30.27 Bn | 830.00 Mn |
| 9 | Steris | 20.68 Bn | 20.20 Bn | 684.20 Mn |
| 10 | Tandem Diabetes Care | 1.27 Bn | 815.45 Mn | 144.78 Mn |